000 01373 a2200373 4500
005 20250517142718.0
264 0 _c20170329
008 201703s 0 0 eng d
022 _a1751-2441
024 7 _a10.1080/17512433.2017.1292849
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaccarrone, Mauro
245 0 0 _aCannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
_h[electronic resource]
260 _bExpert review of clinical pharmacology
_cApr 2017
300 _a443-455 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdministration, Oral
650 0 4 _aAnimals
650 0 4 _aCannabidiol
650 0 4 _aCannabinoid Receptor Agonists
_xadministration & dosage
650 0 4 _aDronabinol
650 0 4 _aDrug Combinations
650 0 4 _aDrug Design
650 0 4 _aEndocannabinoids
_xmetabolism
650 0 4 _aHumans
650 0 4 _aPlant Extracts
_xadministration & dosage
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aMaldonado, Rafael
700 1 _aCasas, Miguel
700 1 _aHenze, Thomas
700 1 _aCentonze, Diego
773 0 _tExpert review of clinical pharmacology
_gvol. 10
_gno. 4
_gp. 443-455
856 4 0 _uhttps://doi.org/10.1080/17512433.2017.1292849
_zAvailable from publisher's website
999 _c26952304
_d26952304